Study to Investigate the Immunogenicity, Reactogenicity, and Safety of mRNA-1083 Vaccine (SARS-CoV-2 [COVID-19] and Influenza) in Adults ≥50 Years of Age

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

2,457

Participants

Timeline

Start Date

November 18, 2024

Primary Completion Date

December 10, 2025

Study Completion Date

December 10, 2025

Conditions
COVID-19Influenza
Interventions
BIOLOGICAL

mRNA-1083

Suspension for injection

OTHER

Placebo

0.9% sodium chloride suspension for injection

BIOLOGICAL

Licensed Influenza Vaccine

Aqueous injectable (SC) or suspension for injection (IM)

BIOLOGICAL

SARS-CoV-2 Vaccine

Suspension for injection

Trial Locations (44)

100

National Taiwan University Hospital, Taipei

110

Taipei Medical University - Taipei Medical University Hospital, Taipei

114

Tri-Service General Hospital - Neihu Branch - Infectious Diseases, Taipei

333

Chang Gung Medical Foundation - LinKou Chang Gung Memorial Hospital, Taoyuan District

437

Kuang Tien General Hospital - Dajia, Taichung

704

National Cheng Kung University Hospital, Tainan City

807

Kaohsiung Medical University - Chung-Ho Memorial Hospital, Kaohsiung City

13620

Seoul National University Bundang Hospital, Seongnam-si

15355

Korea University Ansan Hospital, Ansan-si

16499

Ajou University Hospital, Suwon

22332

Inha University Hospital, Incheon

61469

Chonnam National University Hospital - Allergology, Gwangju

453-0804

Public Health Association.Inc., Nagoya

457-8511

Daido Clinic, Nagoya

810-0021

Tenjin Sogo Clinic, Fukuoka

812-0025

PS Clinic - Internal medicine, Fukuoka

819-0002

Fukuoka Heartnet Hospital, Fukuoka

060-0011

Medical Coporation of Yamazaki Neurotology, Rhinolaryngology Clinical, Sapporo

231-0023

Motomachi Takatsuka Naika Clinic - Internal Medicine, Yokohama

860-0833

Sakurajyuji Medical Corporation Medimesse Sakurajyuji Clinic, Kumamoto

861-4157

Nishi-Kumamoto Hospital, Kumamoto

989-6143

Sato Hospital, Osaki-shi

562-0003

Yokoi Medicine Clinic, Mino

120-0022

Shinwakai Adachi Kyosai Hospital - Internal Medicine, Adachi-ku

101-0041

Dojinkinenkai Meiwa Hospital, Chiyoda-ku

103-0025

Nihonbashi Sakura Clinic, Chuo-ku

103-0027

Tokyo center clinic - Internal medicine, Chuo-ku

104-0031

Medical Corporation Asbo Tokyo Asbo Clinic, Chuo-ku

192-0046

New Medical Research System Clinic, Hachioji-shi

177-0051

Shimamura Memorial Hospital, Nerima City

145-0071

Denenchofu Family Clinic, Ōta-ku

150-0001

Hillside Clinic Jingumae, Shibuya-ku

160-0004

Clinical Research Tokyo Hospital - Clinical Research Center, Shinjuku

169-0072

Higashi-Shinjuku Clinic - Internal Medicine, Shinjuku

166-0003

Shinei Medical Healthcare Clinic, Suginami

130-0004

Souseikai Sumida Hospital, Sumida-Ku

111-0036

Seishukai Clinic, Taito-ku

171-0021

Metropolitan Clinic - Internal Medicine, Toshima-ku

Unknown

Kyungpook National University Hospital - Infectious Diseases, Daegu

Yonsei University, Wonju Severance Christian Hospital, Wŏnju

03722

Severance Hospital, Yonsei University Health System, Seoul

07441

Hallym University Kangnam Sacred Heart Hospital, Seoul

08308

Korea University Guro Hospital, Seoul

813 404

Kaohsiung Veterans General Hospital, Kaohsiung City

All Listed Sponsors
lead

ModernaTX, Inc.

INDUSTRY

NCT06694389 - Study to Investigate the Immunogenicity, Reactogenicity, and Safety of mRNA-1083 Vaccine (SARS-CoV-2 [COVID-19] and Influenza) in Adults ≥50 Years of Age | Biotech Hunter | Biotech Hunter